We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Oxford COVID-19 Vaccine Shows Sustained Protection as Initial Dose
Oxford COVID-19 Vaccine Shows Sustained Protection as Initial Dose
The AstraZeneca/Oxford University COVID-19 vaccine offers sustained protection of 76 percent effectiveness for three months following an initial dose, Oxford researchers reported in early results from multiple trials in the UK, Brazil and South Africa.